文献速递咽喉与嗓音小儿耳鼻咽喉

儿童反常声带运动障碍诊治后哮喘药物使用减少

Reduced Asthma Medication Use after Treatment of Pediatric Paradoxical Vocal Fold Motion Disorder.
PubMed 文献 · Laryngoscope · 2020-12-04

这项前瞻性观察研究纳入26例11–17岁新诊断儿童反常声带运动障碍(PVFMD)患者,评估诊断与喉控制治疗(LCT)后哮喘药物使用及呼吸困难变化。完全治疗组及仅运动诱发组哮喘药物使用显著减少(P < .05),呼吸困难指数(DI)总体从25.5降至18.8(P < .001)。

要点

  • 儿童PVFMD诊治后,完成至少两次LCT者的哮喘药物使用显著减少。
  • 仅以运动为诱因的PVFMD患者,治疗后哮喘药物使用也显著减少。
  • LCT使儿童PVFMD患者的呼吸困难指数(DI)显著下降。

核心结论

  • 儿童PVFMD的诊断与治疗可使参与至少两次LCT的患者及运动诱发PVFMD患者的哮喘药物使用减少。
  • LCT可使儿童PVFMD患者的呼吸困难症状(DI评分)显著改善。

研究设计与样本

  • 前瞻性观察研究,在单一儿童机构招募11–17岁新诊断PVFMD患者。
  • 在初诊、第一次复诊及诊断治疗6个月后完成药物问卷与呼吸困难指数(DI)。

主要发现

  • 19/26(73%)患者在诊断PVFMD前已诊断哮喘,26/26(100%)患者在入组前使用吸入剂。
  • 完全治疗组哮喘药物使用显著减少(P < .05)。
  • 仅以运动为诱因者哮喘药物使用显著减少(P < .05)。
  • DI评分总体从25.5降至18.8(P < .001)。

关键数值与推荐

  • LCT包括教授呼吸技术及识别并减少情绪、生理和环境诱发因素的策略。
  • 治疗分组:5例未治疗,7例部分治疗,14例完全治疗。

临床怎么用

  • 对儿童PVFMD应尽早诊断并开展LCT,以减少不必要的哮喘药物使用。
  • 对运动诱发PVFMD患者,LCT可显著减少哮喘药物使用并改善呼吸困难。

局限性

  • 研究为单中心前瞻性观察研究,证据等级为4级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESES: The primary objective of this study was to determine whether the diagnosis and treatment of pediatric Paradoxical Vocal Fold Motion Disorder (PVFMD) leads to decreased asthma medication use. Our secondary objective was to determine dyspnea outcomes following diagnosis and treatment for PVFMD. STUDY DESIGN: Prospective observational study. METHODS: Patients with newly diagnosed PVFMD between the ages of 11 and 17 were recruited at a single pediatric institution. A medication questionnaire and Dyspnea Index (DI) were completed at the initial visit, at the first return visit, and at greater than 6 months post-diagnosis and therapy. Laryngeal Control Therapy (LCT) consisted of teaching breathing techniques and identifying emotional, physical, and environmental contributing factors and strategies to reduce them. RESULTS: Twenty-six patients were recruited to the study. There were 19/26 (73%) patients diagnosed with asthma prior to a diagnosis of PVFMD, and 26/26 (100%) patients were using an inhaler prior to the enrollment visit. Twenty-two (85%) patients completed follow-up questionnaires. Five patients participated in no therapy, seven patients in partial therapy, and 14 patients in full therapy. Significant reduction in asthma medication use was seen in the full therapy group (P < .05) and in those with exercise as their only trigger (P < .05). Furthermore, symptoms as scored by the DI decreased overall from 25.5 to 18.8 (P < .001). CONCLUSIONS: Diagnosis and treatment of pediatric PVFMD leads to a decline in asthma medication use in those patients who participate in at least two LCT sessions and in those with exercise-induced PVFMD. LCT for pediatric PVFMD leads to a significant decrease in symptoms as measured by the DI. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:1639-1646, 2021.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Ivancic R, Matrka L, Wiet G, et al. Reduced Asthma Medication Use after Treatment of Pediatric Paradoxical Vocal Fold Motion Disorder. Laryngoscope. 2020. PMID: 33274767. doi:10.1002/lary.29283

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。